trichomonas
Aptitude Medical Systems Gets Gates Foundation Grant for At-Home STI Test
The funding will support development of a point-of-care and over-the-counter molecular diagnostic to detect chlamydia, gonorrhea, and trichomonas.
Becton Dickinson High-Throughput MDx Module, Triplex STI Test Get FDA 510(k)Clearance
Along with a sample prep module, the BD Cor MX module is capable of delivering as many as 1,000 sample results in 24 hours.
BD Gets CE Mark, Australian Regulatory Approval for New Cor MX Instrument
The new MX instrument, which is based on the firm's BD Max PCR instrument, is the final component of the high-throughput BD Cor system.
The firm received clearance and CLIA waiver for a 30-minute point-of-care PCR assay for three common STIs earlier this week.
Visby Medical Obtains FDA 510(k), CLIA Waiver for Multiplex STI Test Using Handheld PCR Device
The CLIA waiver enables clinicians to run a 30-minute multiplex test for chlamydia, gonorrhea, and trichomonas during a patient's visit.
Jan 31, 2020
NeuMoDx T. Vaginalis, M. Genitalium Assay CE Marked
Apr 23, 2018
Sep 14, 2016
Becton Dickinson Triplex STD Test Clears FDA Review
Jul 27, 2016
Hologic Q3 Revenues Up 3 Percent
Mar 20, 2015
BD Gains CE Mark for STD MDx Assays
Mar 17, 2015